Jennison Associates LLC Innoviva, Inc. Transaction History

Jennison Associates LLC

$155 Billion
Q2 2024

A detailed history of Jennison Associates LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Jennison Associates LLC holds 103,227 shares of INVA stock, worth $2.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

103,227

Previous 77,492 33.21%

Holding current value

$2.07 Million

Previous $1.18 Million 43.39%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$14.4 - $16.4 $370,584 - $422,053	25,735 Added 33.21%	103,227 $1.69 Million
Q1 2024 May 02, 2024	BUY	$14.56 - $16.78 $513,880 - $592,233	35,294 Added 83.64%	77,492 $1.18 Million
Q4 2023 Feb 01, 2024	SELL	$12.32 - $16.27 $528,195 - $697,543	-42,873 Reduced 50.4%	42,198 $676,000
Q3 2023 Oct 31, 2023	BUY	$12.37 - $13.89 $438,269 - $492,122	35,430 Added 71.37%	85,071 $1.11 Million
Q2 2023 Aug 03, 2023	BUY	$11.39 - $13.72 $565,410 - $681,074	49,641 New	49,641 $631,000
Q4 2022 Feb 09, 2023	SELL	$11.8 - $13.78 $240,153 - $280,450	-20,352 Reduced 21.62%	73,801 $977,000
Q3 2022 Nov 01, 2022	BUY	$11.61 - $15.22 $14,164 - $18,568	1,220 Added 1.31%	94,153 $1.09 Million
Q2 2022 Aug 02, 2022	SELL	$14.32 - $19.88 $1,245 - $1,729	-87 Reduced 0.09%	92,933 $1.37 Million
Q1 2022 May 11, 2022	SELL	$15.39 - $20.25 $509,993 - $671,044	-33,138 Reduced 26.27%	93,020 $1.8 Million
Q4 2021 Feb 08, 2022	BUY	$15.91 - $18.72 $823,215 - $968,610	51,742 Added 69.53%	126,158 $2.18 Million
Q3 2021 Nov 09, 2021	BUY	$13.06 - $17.24 $971,872 - $1.28 Million	74,416 New	74,416 $1.24 Million

Others Institutions Holding INVA

# of Institutions

221

Shares Held

79.5M

Call Options Held

20K

Put Options Held

5.4K

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.4B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.

Account

Jennison Associates LLC Innoviva, Inc. Transaction History